Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$935M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$606M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$598M |
| 4 |
Alibaba
BABA
|
+$340M |
| 5 |
SPDR Gold Trust
GLD
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$47.4M |
| 2 |
Linde
LIN
|
+$29.9M |
| 3 |
Walmart Inc
WMT
|
+$28.5M |
| 4 |
Microsoft
MSFT
|
+$28.4M |
| 5 |
Deere & Co
DE
|
+$26.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 24.27% |
| 2 | Consumer Discretionary | 16.92% |
| 3 | Healthcare | 15.14% |
| 4 | Financials | 5.73% |
| 5 | Industrials | 3.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Cintas
CTAS
$81.3B
| $1.1M | 0.01% |
+11,604
| New | +$1.14M |
|
502
Akamai
AKAM
$15.9B
| $1.09M | 0.01% |
10,413
-4,634
| -31% | -$529K |
|
503
BioMarin Pharmaceuticals
BMRN
$12.4B
| $1.08M | 0.01% |
14,010
-9,171
| -40% | -$724K |
|
504
National Healthcare
NHC
$3.38B
| $1.08M | 0.01% |
15,469
-381
| -2% | -$27.7K |
|
505
Twilio
TWLO
$36.6B
| $1.08M | 0.01% |
+3,371
| New | +$1.23M |
|
|
VRN
506
DELISTED
Veren
VRN
| $1.07M | 0.01% |
232,668
-2,727
| -1% | -$10.1K |
|
507
Cerus
CERS
$474M
| $1.07M | 0.01% |
175,280
-4,518
| -3% | -$26.3K |
|
508
Macerich
MAC
$6.92B
| $1.05M | 0.01% |
63,037
+2,906
| +5% | +$49.3K |
|
509
O'Reilly Automotive
ORLY
$76.3B
| $1.05M | 0.01% |
+25,860
| New | +$1.04M |
|
|
TSP
510
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $1.05M | 0.01% |
+28,191
| New | +$1.19M |
|
511
Verisk Analytics
VRSK
$25B
| $1.04M | 0.01% |
+5,195
| New | +$1.01M |
|
512
BellRing Brands
BRBR
$1.34B
| $1.04M | 0.01% |
33,783
+26,158
| +343% | +$837K |
|
|
VRAY
513
DELISTED
ViewRay, Inc.
VRAY
| $1.04M | 0.01% |
+143,930
| New | +$909K |
|
514
AngioDynamics
ANGO
$649M
| $1.04M | 0.01% |
39,956
-165
| -0.4% | -$4.41K |
|
515
Hartford Financial Services
HIG
$39.3B
| $1.02M | 0.01% |
14,579
+426
| +3% | +$28.2K |
|
516
Netflix
NFLX
$309B
| $1.02M | 0.01% |
+16,720
| New | +$920K |
|
517
Tenet Healthcare
THC
$21.1B
| $1.02M | 0.01% |
15,285
+3,061
| +25% | +$217K |
|
518
LeMaitre Vascular
LMAT
$1.86B
| $1.01M | 0.01% |
+18,952
| New | +$1.07M |
|
519
Nike
NKE
$61.9B
| $997K | 0.01% |
+6,864
| New | +$1.12M |
|
|
WRK
520
DELISTED
WestRock Company
WRK
| $989K | 0.01% |
19,848
+813
| +4% | +$41.1K |
|
521
Transmedics
TMDX
$2.91B
| $970K | 0.01% |
29,326
+121
| +0.4% | +$3.7K |
|
522
Atmos Energy
ATO
$28.8B
| $941K | 0.01% |
10,672
+355
| +3% | +$34.3K |
|
523
NRC Health Common Stock
NRC
$450M
| $939K | 0.01% |
22,275
-862
| -4% | -$43.4K |
|
524
Copart
CPRT
$27.5B
| $936K | 0.01% |
+26,996
| New | +$965K |
|
525
Edison International
EIX
$26.4B
| $936K | 0.01% |
16,877
+560
| +3% | +$32.1K |
|
Similar funds
Ray Dalio's Q3 2021 Portfolio in Review
As of Q3 2021, Ray Dalio held 821 positions worth $18.3B, up 17% from $15.6B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Ray Dalio deployed $3.42B of net new capital in Q3 2021, opening 117 new positions and adding to 343 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 8,990,211 shares worth $70M.
By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Danaher, an estimated $47.4M trimmed.
- Ray Dalio's largest Q3 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 8,990,211 shares worth $70M.
- Ray Dalio added most to iShares MSCI Emerging Markets ETF in Q3 2021, an estimated $935M increase.
- Ray Dalio's biggest Q3 2021 reduction was Danaher, cutting an estimated $47.4M.
- Ray Dalio fully exited Linde in Q3 2021, selling an estimated $29.9M.
- Ray Dalio's ten largest holdings make up 38% of its $18.3B portfolio in Q3 2021.
- Ray Dalio opened 117 new positions and closed 138 in Q3 2021.
- Ray Dalio's portfolio value rose 17% quarter-over-quarter to $18.3B.
Based on Bridgewater Associates's 13F filing for Q3 2021, filed 12 Nov 2021.